Literature DB >> 21246028

Correspondence (letter to the editor):Pain Therapy.

Markus Gehling.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21246028      PMCID: PMC3021908          DOI: 10.3238/arztebl.2010.0900a

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  4 in total

1.  Cause-specific cardiovascular risk associated with nonsteroidal antiinflammatory drugs among healthy individuals.

Authors:  Emil Loldrup Fosbøl; Fredrik Folke; Søren Jacobsen; Jeppe N Rasmussen; Rikke Sørensen; Tina Ken Schramm; Søren S Andersen; Søren Rasmussen; Henrik Enghusen Poulsen; Lars Køber; Christian Torp-Pedersen; Gunnar H Gislason
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-06-08

2.  Fracture risk associated with the use of morphine and opiates.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  J Intern Med       Date:  2006-07       Impact factor: 8.989

3.  Potentially inappropriate medications in the elderly: the PRISCUS list.

Authors:  Stefanie Holt; Sven Schmiedl; Petra A Thürmann
Journal:  Dtsch Arztebl Int       Date:  2010-08-09       Impact factor: 5.594

4.  Baseline factors associated with congestive heart failure in patients receiving etoricoxib or diclofenac: multivariate analysis of the MEDAL program.

Authors:  Henry Krum; Sean P Curtis; Amarjot Kaur; Hongwei Wang; Steven S Smugar; Matthew R Weir; Loren Laine; D Craig Brater; Christopher P Cannon
Journal:  Eur J Heart Fail       Date:  2009-04-19       Impact factor: 15.534

  4 in total
  2 in total

1.  Characteristics and drug use patterns of older antidepressant initiators in Germany.

Authors:  Kathrin Jobski; Niklas Schmedt; Bianca Kollhorst; Jutta Krappweis; Tania Schink; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2016-10-18       Impact factor: 2.953

2.  Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list.

Authors:  Ute Amann; Niklas Schmedt; Edeltraut Garbe
Journal:  Dtsch Arztebl Int       Date:  2012-02-03       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.